do Nascimento Jonas Lira, da Costa Michely Conceição Viana, de Macêdo Leticia Farias, de Macêdo Luiz Henrique Chaves, de Moura Ricardo Olímpio, de Mélo Tomás Jeferson Alves, da Rocha Wilma Raianny Vieira, de Melo Costa Ana Cristina Figueiredo, Soares-Sobrinho José Lamartine, Silva Dayanne Tomaz Casimiro da
Pharmaceutical Sciences Postgraduate Program, Paraiba State University, UEPB, Campina Grande 58429-500, PB, Brazil.
Pharmacy Department, Paraiba State University, UEPB, Campina Grande 58429-500, PB, Brazil.
Pharmaceutics. 2025 Sep 22;17(9):1234. doi: 10.3390/pharmaceutics17091234.
: Silver sulfadiazine (AgSD) is widely used in the topical treatment of burns and infected wounds, but its conventional formulations present drawbacks such as poor water solubility, the need for multiple daily applications, and patient discomfort. To overcome these limitations, this study aimed to develop and evaluate Laponite (LAP)-based hydrogels loaded with AgSD for controlled release and enhanced antimicrobial and antibiofilm efficacy, offering a promising alternative for the treatment of contaminated or biofilm-forming wounds. : Laponite-based hydrogels containing 1% and 1.2% AgSD (LAP@AgSD) were prepared using a one-pot method. The formulations were characterized rheologically, thermally, and structurally. In vitro drug release was assessed using Franz diffusion cells, and mathematical modeling was applied to determine release kinetics. Antibacterial and antibiofilm activities were evaluated against , , and using standardized microbiological methods. : LAP@AgSD hydrogels exhibited pseudoplastic behavior, high structural integrity, and enhanced thermal stability. In vitro release assays revealed a sustained release profile, best fitted by the Weibull model, indicating diffusion-controlled mechanisms. Antibacterial assays demonstrated concentration-dependent activity, with LAP@AgSD 1.2% showing superior efficacy over LAP@AgSD 1% and comparable performance to the commercial silver sulfadiazine cream (CC-AgSD). Biofilm inhibition was significant for all formulations, with CC-AgSD 1% exhibiting the highest immediate activity, while LAP@AgSD 1.2% provided sustained antibiofilm potential. : LAP-based hydrogels are promising smart delivery systems for AgSD, combining mechanical robustness, controlled drug release, and effective antibacterial and antibiofilm activities. These findings support their potential use in topical therapies for infected and chronic wounds, particularly where biofilm formation is a challenge.
磺胺嘧啶银(AgSD)广泛用于烧伤和感染伤口的局部治疗,但其传统制剂存在诸如水溶性差、需要每日多次应用以及患者不适等缺点。为克服这些局限性,本研究旨在开发和评估负载AgSD的基于锂皂石(LAP)的水凝胶,以实现控释并增强抗菌和抗生物膜功效,为受污染或形成生物膜的伤口治疗提供一种有前景的替代方案。:采用一锅法制备了含1%和1.2% AgSD的基于LAP的水凝胶(LAP@AgSD)。对制剂进行了流变学、热学和结构表征。使用Franz扩散池评估体外药物释放,并应用数学模型确定释放动力学。采用标准化微生物学方法评估对金黄色葡萄球菌、大肠杆菌和铜绿假单胞菌的抗菌和抗生物膜活性。:LAP@AgSD水凝胶表现出假塑性行为、高结构完整性和增强的热稳定性。体外释放试验显示出缓释曲线,最适合威布尔模型,表明为扩散控制机制。抗菌试验证明具有浓度依赖性活性,1.2%的LAP@AgSD比1%的LAP@AgSD表现出更高的功效,且性能与市售磺胺嘧啶银乳膏(CC - AgSD)相当。所有制剂对生物膜的抑制作用均显著,1%的CC - AgSD表现出最高的即时活性,而1.2%的LAP@AgSD具有持续的抗生物膜潜力。:基于LAP的水凝胶是用于AgSD的有前景的智能递送系统,兼具机械稳健性、控释以及有效的抗菌和抗生物膜活性。这些发现支持了它们在感染性和慢性伤口局部治疗中的潜在应用,特别是在生物膜形成是一个挑战的情况下。